Published in

Oxford University Press, Open Forum Infectious Diseases, 8(8), 2021

DOI: 10.1093/ofid/ofab369

Links

Tools

Export citation

Search in Google Scholar

Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual

Journal article published in 2021 by Solen Kernéis, Delphine Planas, Sandrine Imbeaud, Isabelle Staropoli, Julien Puech, Nicolas Robillard, Julien Rodary, Timothée Bruel ORCID, Thomas Vieillard, Olivier Schwartz, Laurent Belec, Hélène Péré, David Veyer
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
White circle
Published version: policy unclear
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Abstract Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.